Twice Negative PCR in a Patient With Herpes Simplex Virus Type 1 (HSV-1) Encephalitis

被引:7
|
作者
Roberts, Jodie, I [1 ]
Jewett, Gordon A. E. [1 ]
Tellier, Raymond [2 ]
Couillard, Philippe [1 ,3 ,4 ]
Peters, Steven [1 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Div Neurol, Calgary, AB, Canada
[2] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada
[4] McGill Univ, Dept Med, Div Infect Dis, Montreal, PQ, Canada
来源
NEUROHOSPITALIST | 2021年 / 11卷 / 01期
关键词
herpes simplex virus; viral encephalitis; false-negative PCR; acyclovir; CEREBROSPINAL-FLUID; ACYCLOVIR; DIAGNOSIS;
D O I
10.1177/1941874420943031
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Untreated herpes simplex virus type I (HSV- 1) encephalitis is associated with high mortality. Missed cases can have devastating consequences. Detection of HSV-1 in cerebrospinal fluid (CSF) with polymerase chain reaction (PCR) is reported to have high sensitivity and specificity and is considered the diagnostic gold standard for HSV-1 encephalitis. In this article, we report a case of autopsy-confirmed HSV-1 encephalitis where CSF PCR returned negative on 2 occasions. A 64-year-old man presented with fever, left-sided weakness, and altered level of consciousness. Magnetic resonance imaging demonstrated right mesial temporal lobe diffusion restriction and electroencephalography showed right lateralized periodic discharges. Lumbar puncture was performed on day I for which CSF PCR returned negative for HSV-1. Empiric antiviral and antibiotic treatments were continued due to high clinical suspicion of HSV-1 encephalitis. Repeat lumbar puncture on day 5 was unchanged and empiric treatments were discontinued. On day 13, he developed status epilepticus requiring intensive care unit admission. A third CSF sample returned positive for HSV-1. Acyclovir was restarted but he continued to clinically worsen and supportive care was withdrawn. Autopsy confirmed widespread HSV-1 meningoencephalitis. Negative CSF PCR should be interpreted with caution in cases where there is high clinical suspicion of HSV-1 encephalitis. Current guidelines suggest repeating CSF HSV-1 PCR within 3 to 7 days in suspicious cases while continuing empiric therapy. However, missed cases can occur even with repeated testing. Empiric treatment with acyclovir should be considered in cases with high clinical suspicion of HSV-1 encephalitis, while investigations for alternate treatable diagnoses are continued.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 50 条
  • [1] Herpes simplex virus type 1 (HSV-1)-induced retinitis following herpes simplex encephalitis: Indications for brain-to-eye transmission of HSV-1
    Maertzdorf, J
    Van der Lelij, A
    Baarsma, AS
    Osterhaus, ADME
    Verjans, GMGM
    ANNALS OF NEUROLOGY, 2000, 48 (06) : 936 - 939
  • [2] Herpes simplex virus type 1 (HSV-1)-induced retinitis following herpes simplex encephalitis: Indications for brain-to-eye transmission of HSV-1
    Maertzdorf, J
    Van der Lelij, A
    Baarsma, GS
    Osterhaus, ADME
    Verjans, GMGM
    ANNALS OF NEUROLOGY, 2001, 49 (01) : 104 - 106
  • [3] Herpes Simplex Virus type 1 (HSV-1)-induced acute retinal necrosis following HSV-1 encephalitis: A sequel of infection with the same virus
    Maertzdorf, J
    Van der Lelij, A
    Baarsma, GS
    Osterhaus, ADME
    Verjans, GMGM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S780 - S780
  • [4] The two helicases of herpes simplex virus type 1 (HSV-1)
    Chattopadhyay, Soma
    Chen, Yan
    Weller, Sandra K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2213 - 2223
  • [5] Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes
    Nieuwenhuis, RF
    van Doornum, GJJ
    Mulder, PGH
    Neumann, HAM
    van der Meijden, WI
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (02) : 129 - 134
  • [6] The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1
    Mador, N
    Panet, A
    Steiner, I
    JOURNAL OF NEUROVIROLOGY, 2002, 8 : 97 - 102
  • [7] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Shen, Y.
    Nemunaitis, J.
    CANCER GENE THERAPY, 2006, 13 (11) : 975 - 992
  • [8] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Y Shen
    J Nemunaitis
    Cancer Gene Therapy, 2006, 13 : 975 - 992
  • [9] Recovery of lesion infiltrating herpes simplex virus (HSV) type 1 specific T cells in a patient with primary HSV-1 genital herpes
    Roest, RW
    van Dijk, G
    Kant, R
    van der Meijden, WI
    Osterhaus, ADME
    Verjans, GMGM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 584 - 584
  • [10] The role of IFNγ during herpes simplex virus type 1(HSV-1) latency
    Deeman, V
    Kinchington, PR
    Hendricks, RL
    FASEB JOURNAL, 2003, 17 (07): : C169 - C169